# Standard Lithium Ltd. (SLI) fundamentals

Data as of 2026-09-08. AMEX, United States. Sector: Basic Materials / Metals & Mining. Price $2.42, market value $597 million.

## Valuation
- **P/E (trailing): n/a** (negative earnings). Standard Lithium Ltd. reported negative earnings over the last twelve months, so the P/E is not meaningful; use price-to-sales, EV/EBITDA and free-cash-flow yield instead.
- **Price / book: 1.6×**. The shares trade at 1.6× book value; book value is a meaningful part of the valuation.
- **Free-cash-flow yield: -2.0%**. Free cash flow is negative: the business is consuming cash, which is normal for heavy investment phases but a warning otherwise.

## Profitability
- **Return on equity: -13.7%**. Return on equity is negative because earnings are negative.

## Financial health
- **Current ratio: 15.63** (quick 15.63). Current assets cover the next year's liabilities 15.63 times.

## Dividends
- **Dividend: none**. Standard Lithium Ltd. does not currently pay a dividend, but it returned -29.2% of its market value through buybacks over the last year.

## Analyst view
- **Analyst consensus: strong_buy** (4 analysts). 4 analysts cover Standard Lithium Ltd.; the consensus is strong_buy, with an average price target of $4.68 (+93% from the current price). Analyst opinion is shown for context; it is not part of the Fundamental Score.

## Price and momentum
- **Total return (1 yr): -15.7%** (YTD -45.9%, 3-mo -30.3%). The shares are down 15.7% over twelve months including dividends.
- **From 52-week high: -62.2%** (26.7% above the low). Trading 62% below its 52-week high, deep in a drawdown.
- **200-day average: below**. The price sits below its 200-day moving average, the usual definition of a downtrend.
- **RSI (14-day): 49**. An RSI of 49 is neutral.
- **Beta (1 yr): 2.04** (volatility 77%). Beta of 2.04 against the S&P 500: the shares move much more than the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=SLI · Page: https://foliofundamentals.com/stocks/sli

Not investment advice.